CYTO Message Board - Msg: 3955889

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYTO

CYTO 0.300

0.0%

Dec 19 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rod who wrote (7164)	4/4/1998 5:25:00 AM
From: Bernard I. Gentile	Read Replies (1) of 8116

Anybody knows how Sm-153 is produced by this "sole source supplier"? From the last 10K: "Certain components of Quadramet, particularly Sm-153 and EDTMP, are provided to DuPont Merck by sole source suppliers. Due to its radiochemical properties, Sm-153 must be produced on a weekly basis by its supplier in order to meet DuPont Merck's manufacturing requirements. On one occasion, DuPont Merck was unable to manufacture Quadramet on a timely basis due to the failure of the sole source supplier to provide an adequate supply of Sm-153. In the event that DuPont Merck is unable to obtain sufficient quantities of such components on commercially reasonable terms, or in a timely manner, DuPont Merck would be unable to manufacture Quadramet on a timely and cost-competitive basis. In addition, alternative sources for certain of these components may not be readily available."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next